Division 1 Record checks, clinical inspections and laboratory examinations at the approved aquaculture establishments referred to in Articles 7, 17 and 18 shall be carried out as follows:

the relevant records kept in accordance with the record-keeping obligations of Article 186 of Regulation (EU) 2016/429 and with Articles 23, 32 and 33 of this Regulation must be examined to assess if there are any indications of increased mortality or the presence of a listed or emerging disease in the aquaculture establishment which must be taken into account during the visit by a veterinarian;

all parts of the aquaculture establishment must be examined with particular attention being paid to those production units where increased mortalities have been indicated in the records referred to in point (a);

where there are no indications of the presence of a listed or emerging disease either from an examination of the records or from the clinical inspection of all production units, there shall be no requirement to take samples for laboratory examination;

where recently dead or moribund aquaculture animals are identified, a representative selection of these aquaculture animals must be examined clinically, both externally and internally, to determine if pathological changes are present; that examination must in particular, aim at detecting listed or emerging diseases;

if the outcome of the clinical examination provided for in point (d) leads to a suspicion of the presence of such a listed or emerging disease in an aquaculture establishment in a Member State, zone or compartment in which an eradication programme is being implemented, or which has been declared free from that particular disease, a sample of aquaculture animals from that aquaculture establishment shall be collected and subjected to a laboratory examination in accordance with the relevant Chapter of Part II of Annex VI to Delegated Regulation (EU) 2020/689;

if the outcome of the clinical examination provided for in point (d) leads to a suspicion of the presence of a listed disease in an aquaculture establishment in which a surveillance programme is being implemented for that particular category C disease, a sample of aquaculture animals from the aquaculture establishment shall be collected and subjected to a laboratory examination in accordance with the relevant Chapter of Part III of Annex VI to Delegated Regulation (EU) 2020/689;

if the outcome of the clinical examination provided for in point (d) leads to the suspicion of an emerging disease, a sample of aquaculture animals from the aquaculture establishment shall be collected and subjected to a laboratory examination with the objective of identifying the emerging disease in question.